Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
ent however have to be raised. The vaccine had to be fine-tuned to b...Shanta Biotechnics was in the process of finalising its plans for ...Various studies and forecasts made on AIDS in India warn of an epi...DBT and the Union Ministry of Health have already started a vaccin......
ent, however, have to be raised. The vaccine had to be fine-tuned to be effective against the HIV variant, prevalent in India, Mr Reddy said.
Shanta Biotechnics was in the process of finalising its plans for a private placement to raise funds both for establishing an US FDA-approved research-cum-manufacturing facility and also to take up joint initiatives with pharma majors like the above, he said.
Various studies and forecasts made on AIDS in India warn of an epidemic with infection numbers being put at nearly 40 lakh at present. With the costs of the few available anti-AIDS drugs still very much beyond the affordability of the victims, a vaccine is being perceived as a welcome development.
DBT and the Union Ministry of Health have already started a vaccine development project under the Indo-US initiative on HIV/AIDS.